Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatorenal syndrome treated for eight months with continuous-flow peritoneal dialysis.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2013
Same author

Year in review 2012: Critical Care--Nephrology.

Critical care (London, England)·2013
Same author

Healthcare systems and chronic kidney disease: putting the patient in control.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2013
Same author

Neutrophil gelatinase associated lipocalin in acute kidney injury.

Postgraduate medicine·2013
Same author

Ultrafiltration therapy for acute decompensated heart failure: lessons learned from 2 major trials.

American heart journal·2013
Same author

Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference.

Kidney international·2013

Related Experiment Video

Updated: Jun 1, 2026

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

Current technological approaches for a wearable artificial kidney.

Jeong Chul Kim, Claudio Ronco

    Contributions to Nephrology
    |June 1, 2011
    PubMed
    Summary

    Wearable artificial kidneys (WAKs) aim to improve dialysis patients' quality of life by supporting renal function outside the hospital. Current WAK development faces technical, ethical, legal, and economic challenges for clinical application.

    Area of Science:

    • Biomedical Engineering
    • Nephrology
    • Medical Devices

    Background:

    • Wearable artificial kidney (WAK) systems are being developed to enhance the quality of life for dialysis patients.
    • Technological advancements in dialysis membranes and dialysate regeneration are enabling progress toward wearable and implantable renal replacement therapies.

    Purpose of the Study:

    • To review the technical requirements for wearable artificial kidney systems.
    • To examine current WAK development efforts and their alignment with these requirements.
    • To discuss non-technical aspects crucial for WAK clinical implementation.

    Main Methods:

    • Literature review of existing wearable artificial kidney technologies.
    • Analysis of technical challenges and requirements for WAK systems.

    More Related Videos

    Use of Enzymatic Biosensors to Quantify Endogenous ATP or H2O2 in the Kidney
    10:00

    Use of Enzymatic Biosensors to Quantify Endogenous ATP or H2O2 in the Kidney

    Published on: October 12, 2015

    Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
    09:43

    Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

    Published on: August 10, 2015

    Related Experiment Videos

    Last Updated: Jun 1, 2026

    Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
    09:00

    Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

    Published on: March 27, 2018

    Use of Enzymatic Biosensors to Quantify Endogenous ATP or H2O2 in the Kidney
    10:00

    Use of Enzymatic Biosensors to Quantify Endogenous ATP or H2O2 in the Kidney

    Published on: October 12, 2015

    Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
    09:43

    Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

    Published on: August 10, 2015

  • Consideration of ethical, legal, and economic factors in WAK development.

    • Main Results:

    • Several WAK systems are under development, driven by innovations in dialysis technology.
    • Significant technical hurdles remain for the widespread clinical application of WAKs.
    • Ethical, legal, and economic considerations are critical for successful WAK implementation.

    Conclusions:

    • Realizing clinical application of wearable artificial kidneys requires addressing numerous technical challenges.
    • A multidisciplinary approach, including ethical, legal, and economic evaluations, is essential.
    • Continuous follow-up and integration with new technologies are necessary for WAK advancement.